01358.HK
PW Medtech Group Limited
HKSE · Healthcare · Medical - Instruments & Supplies · CN
HKD 0.96
+1.60%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.6B | 823.5M | 768.9M | 675.1M | 536.8M |
| Cost of Revenue | 819.1M | 416.0M | 349.5M | 294.2M | 238.0M |
| Gross Profit | 829.4M | 407.5M | 419.4M | 380.9M | 298.8M |
| Operating Expenses | |||||
| R&D Expense | 97.7M | 48.4M | 44.1M | 41.1M | 41.0M |
| SG&A Expense | 537.3M | 268.9M | 240.9M | 195.1M | 189.6M |
| General & Admin Expense | 268.7M | 172.2M | 156.8M | 119.0M | 122.1M |
| Selling & Marketing Expense | 140.8M | 96.7M | 84.1M | 76.1M | 67.5M |
| Other Expenses | (53.0M) | (32.1M) | (45.0M) | (42.7M) | (54.6M) |
| Total Operating Expenses | 582.0M | 285.2M | 240.0M | 193.5M | 176.0M |
| Cost and Expenses | 1.4B | 701.2M | 589.4M | 487.7M | 414.0M |
| Operating Income (EBIT) | 247.4M | 122.3M | 179.5M | 187.4M | 122.8M |
| Non-Operating | |||||
| Interest Income | 80.3M | 43.4M | 50.6M | 43.8M | 35.4M |
| Interest Expense | 771.9K | 720.0K | 374.0K | 154.0K | 464.0K |
| Net Interest Income | 79.5M | 42.7M | 50.3M | 43.7M | 34.9M |
| Other Non-Op Income/Expense | 85.9M | 42.7M | 50.3M | 43.7M | 34.9M |
| Non-Operating Income (excl Interest) | 94.0K | (3.4M) | 5.5M | (43.8M) | 24.7M |
| EBT (Pre-Tax Income) | 333.3M | 165.0M | 229.8M | 231.1M | 157.7M |
| Income Tax Expense | 61.5M | 29.7M | 37.2M | 26.0M | 28.9M |
| Bottom Line | |||||
| Net Income | 189.6M | 94.4M | 150.8M | 153.2M | 106.0M |
| Earnings from Cont. Ops | 271.9M | 135.3M | 192.5M | 205.0M | 128.9M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 189.6M | 94.4M | 150.8M | 153.2M | 106.0M |
| Per Share | |||||
| Basic EPS | HK$0.13 | HK$0.06 | HK$0.10 | HK$0.10 | HK$0.07 |
| Diluted EPS | HK$0.13 | HK$0.06 | HK$0.10 | HK$0.10 | HK$0.07 |
| Revenue Per Share | HK$1.13 | HK$0.55 | HK$0.50 | HK$0.43 | HK$0.34 |
| Shares | |||||
| Basic Shares Outstanding | 1.5B | 1.5B | 1.5B | 1.6B | 1.6B |
| Diluted Shares Outstanding | 1.5B | 1.5B | 1.5B | 1.6B | 1.6B |
| Profitability Metrics | |||||
| EBITDA | 495.9M | 262.9M | 271.0M | 329.5M | 175.5M |
| D&A | 248.6M | 137.1M | 97.0M | 98.3M | 77.3M |
| EBIT | 247.3M | 125.7M | 174.0M | 231.2M | 98.2M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026